Management of primary or secondary sclerosing cholangitis is challenging. These Clinical
Practice Guidelines have been developed to provide practical guidance on debated topics …

Primary sclerosing cholangitis (PSC) is a rare cholestatic liver disease, characterized by
multiple strictures and dilatations of the intra-and extrahepatic bile ducts, leading to …

The management of primary sclerosing cholangitis (PSC) is hindered by incomplete
understanding of the pathogenesis of the disease and the lack of good prognostic models …

This guideline has been approved by the American Association for the Study of Liver
Diseases and represents the position of the Association. These recommendations provide a …

Primary sclerosing cholangitis (PSC) is a chronic immune-mediated disease of the liver of
unclear etiology, characterized by chronic inflammation and fibrosis of bile ducts. It primarily …

Primary sclerosing cholangitis is a chronic cholestatic liver disease that can shorten life and
may require liver transplantation. The cause is unknown, although it is commonly associated …

Primary Sclerosing Cholangitis | NEJM Skip to main content NEJM Group Follow Us Facebook
Twitter Instagram YouTube LinkedIn Prepare to become a physician, build your knowledge …

PREAMBLE Guidelines for clinical practice are intended to indicate preferred approaches to
medical problems as established by scientifically valid research. Double blind, placebo …

Primary sclerosing cholangitis (PSC) is a rare, but serious, cholestatic disease for which, to
date, no effective therapy exists to halt disease progression toward end‐stage liver disease …

Objective To describe primary sclerosing cholangitis (PSC) and its associated
complications, as well as medical and surgical treatment. Design A review of PSC and its …